FDA Inspection
Baxter Healthcare CorporationBaxter Healthcare Corporation – FDA Inspection, Oct 24, 2018
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on October 24, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c1d10e56-429e-4824-ad25-8e7620b75c8b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1069929
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.188(b)(5)In-process and laboratory control results
- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxter Healthcare Corporation
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 26, 2025 | VAI | San Juan District Office | Drug Quality Assurance |
| September 16, 2020 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 13, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1264998 - 2025-03-26
- FDA Inspection 1130593 - 2020-09-16
- FDA Inspection 1000845 - 2016-12-13
- FDA Inspection 913366 - 2015-02-06
- FDA Inspection 863409 - 2013-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.